These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 22932165)
21. Atypical pathogens in adult patients admitted with community-acquired pneumonia in Korea. Lee SJ; Lee MG; Jeon MJ; Jung KS; Lee HK; Kishimoto T Jpn J Infect Dis; 2002 Oct; 55(5):157-9. PubMed ID: 12501255 [TBL] [Abstract][Full Text] [Related]
22. [In vitro resistance rates of Streptococcus pneumoniae and Haemophilus influenzae clinical isolates to the antibiotics used in therapy]. Uncu H; Colakoğlu S; Turunç T; Demiroğlu YZ; Arslan H Mikrobiyol Bul; 2007 Jul; 41(3):441-6. PubMed ID: 17933256 [TBL] [Abstract][Full Text] [Related]
23. [Etiology and outcome of community-acquired pneumonia in relation to age and severity in hospitalized adult patients]. Takayanagi N; Hara K; Tokunaga D; Takaku Y; Minagawa S; Tsuchiya Y; Hijikata N; Yamaji T; Saito H; Ubukata M; Kurashima K; Yanagisawa T; Sugita Y Nihon Kokyuki Gakkai Zasshi; 2006 Dec; 44(12):906-15. PubMed ID: 17233386 [TBL] [Abstract][Full Text] [Related]
24. Antimicrobial susceptibilities of Streptococcus pneumoniae isolated from adult patients with community-acquired pneumonia in Japan. Ishida T; Maniwa K; Kagioka H; Hirabayashi M; Onaru K; Tomioka H; Hayashi M; Tomii K; Gohma I; Ito Y; Hirai T; Ito I; Mishima M Respirology; 2008 Mar; 13(2):240-6. PubMed ID: 18339022 [TBL] [Abstract][Full Text] [Related]
25. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials. Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462 [TBL] [Abstract][Full Text] [Related]
26. Community-acquired pneumonia in Shanghai, China: microbial etiology and implications for empirical therapy in a prospective study of 389 patients. Huang HH; Zhang YY; Xiu QY; Zhou X; Huang SG; Lu Q; Wang DM; Wang F Eur J Clin Microbiol Infect Dis; 2006 Jun; 25(6):369-74. PubMed ID: 16767484 [TBL] [Abstract][Full Text] [Related]
27. Bacterial aetiology and antimicrobial resistance of community-acquired pneumonia in the elderly and younger adults. Hashemi SH; Soozanchi G; Jamal-Omidi S; Yousefi-Mashouf R; Mamani M; Seif-Rabiei MA Trop Doct; 2010 Apr; 40(2):89-91. PubMed ID: 20305102 [TBL] [Abstract][Full Text] [Related]
28. [Comparative studies on the composition and antibiotic-resistance of pathogenic bacteria between children with community-acquired and hospital-acquired pneumonia]. Wang Z; Ji W; Guo HB; Tao YZ; Ding YF Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Mar; 45(3):211-6. PubMed ID: 21624231 [TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of ten day moxifloxacin 400 mg once daily in the treatment of patients with community-acquired pneumonia. Community Acquired Pneumonia Study Group. Patel T; Pearl J; Williams J; Haverstock D; Church D Respir Med; 2000 Feb; 94(2):97-105. PubMed ID: 10714413 [TBL] [Abstract][Full Text] [Related]
30. A multiplex PCR-based reverse line blot hybridization (mPCR/RLB) assay for detection of bacterial respiratory pathogens in children with pneumonia. Wang Y; Kong F; Yang Y; Gilbert GL Pediatr Pulmonol; 2008 Feb; 43(2):150-9. PubMed ID: 18085683 [TBL] [Abstract][Full Text] [Related]
31. A prospective etiologic study of community-acquired pneumonia in Taiwan. Yen MY; Hu BS; Chen YS; Lee SS; Lin YS; Wann SR; Tsai HC; Lin HH; Huang CK; Liu YC J Formos Med Assoc; 2005 Oct; 104(10):724-30. PubMed ID: 16385374 [TBL] [Abstract][Full Text] [Related]
32. Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia: report from the Community-Acquired Respiratory Tract Infection Pathogen Surveillance (CARTIPS) study, 2009-2010. Wang H; Chen M; Xu Y; Sun H; Yang Q; Hu Y; Cao B; Chu Y; Liu Y; Zhang R; Yu Y; Sun Z; Zhuo C; Ni Y; Hu B; Tan TY; Hsueh PR; Wang JH; Ko WC; Chen YH; Wahjono H Int J Antimicrob Agents; 2011 Nov; 38(5):376-83. PubMed ID: 21880469 [TBL] [Abstract][Full Text] [Related]
33. Sputum bacteriology and antibiotic sensitivity patterns of community-acquired pneumonia in hospitalized adult patients in Nigeria: a 5-year multicentre retrospective study. Iroezindu MO; Chima EI; Isiguzo GC; Mbata GC; Onyedum CC; Onyedibe KI; Okoli LE Scand J Infect Dis; 2014 Dec; 46(12):875-87. PubMed ID: 25288384 [TBL] [Abstract][Full Text] [Related]
34. [What is new in the treatment of community-acquired pneumonia?]. Welte T; Marre R; Suttorp N; Med Klin (Munich); 2006 Apr; 101(4):313-20. PubMed ID: 16607488 [TBL] [Abstract][Full Text] [Related]
35. [Community-acquired pneumonia: pathogens and course in patients admitted to a general hospital]. Braun JJ; de Graaff CS; de Goey J; Zwinderman AH; Petit PL Ned Tijdschr Geneeskd; 2004 Apr; 148(17):836-40. PubMed ID: 15141651 [TBL] [Abstract][Full Text] [Related]